Lifestyle and Lipoprotein(a) Levels: Does a Specific Counseling Make Sense?
Federica FogacciValentina Di MicoliPierre SabouretMarina GiovanniniArrigo Francesco Giuseppe CiceroPublished in: Journal of clinical medicine (2024)
Lipoprotein(Lp)(a) is a variant of low-density lipoprotein (LDL), bound to apolipoprotein B100, whose levels are associated with a significant increase in the risk of atherosclerosis-related cardiovascular events, but also to aortic stenosis and atrial fibrillation. Since plasma levels of Lp(a) are commonly considered resistant to lifestyle changes, we critically reviewed the available evidence on the effect of weight loss, dietary supplements, and physical activity on this risk factor. In our review, we observed that relevant body weight loss, a relatively high intake of saturated fatty acids, the consumption of red wine, and intense physical exercise seems to be associated with significantly lower plasma Lp(a) levels. On the contrary, foods rich in trans-unsaturated fatty acids are associated with increased Lp(a) levels. With regard to dietary supplements, coenzyme Q10, L-Carnitine, and flaxseed exert a mild but significant lowering effect on plasma Lp(a).
Keyphrases
- weight loss
- low density lipoprotein
- physical activity
- cardiovascular events
- fatty acid
- cardiovascular disease
- bariatric surgery
- aortic stenosis
- atrial fibrillation
- metabolic syndrome
- roux en y gastric bypass
- coronary artery disease
- transcatheter aortic valve replacement
- risk factors
- transcatheter aortic valve implantation
- aortic valve replacement
- gastric bypass
- heart failure
- catheter ablation
- direct oral anticoagulants
- sleep quality
- obese patients
- left atrial appendage
- oral anticoagulants